Scarica l'app Stockscreener
14.44
1.19%
0.17
Dopo l'orario di chiusura:
14.44
Precedente Chiudi:
$14.27
Aprire:
$14.04
Volume 24 ore:
456.71K
Relative Volume:
0.68
Capitalizzazione di mercato:
$1.34B
Reddito:
-
Utile/perdita netta:
$-56.88M
Rapporto P/E:
-21.87
EPS:
-0.6604
Flusso di cassa netto:
$-39.43M
1 W Prestazione:
-1.23%
1M Prestazione:
+6.18%
6M Prestazione:
+111.11%
1 anno Prestazione:
+285.07%
Intervallo 1D:
$13.80
$14.81
Intervallo di 1 settimana:
$13.80
$15.17
Portata 52W:
$3.43
$15.17
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Nome
Alpha Tau Medical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare DRTS vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
14.44 | 1.32B | 0 | -56.88M | -39.43M | -0.6604 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | Iniziato | Citigroup | Buy |
| 2023-04-24 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Iniziato | Piper Sandler | Overweight |
| 2022-04-04 | Iniziato | Citigroup | Buy |
Mostra tutto
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - Stocktwits
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Is IMPACT Pilot Enrollment Completion Reshaping The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com Australia
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com
Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough - Seeking Alpha
Alpha Tau to Participate in September Investor Conferences - Alpha Tau Medical
DRTS Stock Price, Quote & Chart - ChartMill
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com Nigeria
Alpha Tau Medical (DRTS) finishes pancreatic IMPACT study signup - Stock Titan
Alpha Tau’s pancreatic cancer study grows from 12 to 48 patients as enrollment closes - Stock Titan
Alpha Tau Medical Ltd. Warrant (DRTSW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Alpha Tau Medical Ltd. Warrant (DRTSW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's What Happened - MarketBeat
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com
Alpha Tau’s Clinical Momentum Put Its Cancer Tech On The Map - Finimize
Price to sales forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – BOATS:DRTSW - TradingView
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical Ltd.: Fundamental Analysis and Financial Ratings | DRTS | IL0011839383 - marketscreener.com
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 15, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 21, 2026) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
Five Takeaways from AHNS 2026: Alpha DaRT in Combination with Immunotherapy for Advanced Head and Neck Cancer - Alpha Tau Medical
ALPHA TAU MEDICAL LTD. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $16 FROM $15 - webull.com
ETFs Investing in Alpha Tau Medical Ltd Stocks - TradingView
Alpha Tau Medical (DRTS) Clinical Progress Tests Whether The Stock Already Looks Fully Valued - simplywall.st
Alpha Tau Medical stock hits 52-week high at 14.12 USD - Investing.com India
Price to earnings forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical Ltd Cash Flow – TASE:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical Ltd Revenue Breakdown – TASE:DRTS - TradingView
Price to earnings ratio of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Free cash flow per share of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical (NASDAQ:DRTS) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Return on invested capital % of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Price to sales ratio of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Enterprise value to revenue forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Enterprise value to EBITDA forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical Ltd Azioni (DRTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):